A first-of-its-kind implant has just been granted approval from the US Food and Drug Administration (FDA) for the treatment ...

A recent study by the University of Pittsburgh and UPMC Hillman Cancer Center revealed that artificial sweeteners may not be ...

The Food and Drug Administration has approved a vagus nerve bioimplant to treat rheumatoid arthritis (RA). The scientific ...

A synthetic microbiome therapy, tested in mice, protects against severe symptoms of a gut infection that is notoriously difficult-to-treat and potentially life threatening in humans, according to ...

A single jab of a breakthrough gene therapy could reverse hearing loss in people within weeks, according to new research.

A Food and Drug Administration (FDA) expert panel has reignited a debate over whether hormone therapy should be used to treat ...

A synthetic microbiome therapy, tested in mice, holds promise as a new treatment for C. difficile, a notoriously difficult-to-treat bacterial infection, according to a team of researchers at Penn ...

Immune cells (NK and cytotoxic T cells) are activated by short-synthetic mRNA which binds to the ZC3H12D receptor and is transported to the nucleus where it induces the expression of GZMB, a key ...

The company is working on a synthetic DNA-based therapy for the treatment of pulmonary arterial hypertension (PAH), and hopes to add additional synthetic DNA programs in the near-term.